Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system.

Scott L Dryden-PetersonAndy KimArthur Y KimEllen C CanigliaInga LennesRajesh PatelLindsay GainerLisa DuttonElizabeth DonahueRajesh T GandhiLindsey R BadenAnn E Woolley

Published in: medRxiv : the preprint server for health sciences (2022)

National Institutes of Health (P30 AI060354 and R01 CA236546).

Keyphrases

coronavirus disease
sars cov
public health
healthcare
artificial intelligence
mental health
quality improvement
health information
antiretroviral therapy
health promotion
risk assessment
climate change
deep learning